August 13, 2019
Video
Heather A. Wakelee, MD, discusses recent research investigating antiangiogenic agents and checkpoint inhibitors in the frontline for patients with EGFR-positive non—small cell lung cancer. The most promising data were demonstrated in the phase III IMpower150 trial.
January 25, 2019
Video
Heather A. Wakelee, MD, discusses the use of osimertinib as a frontline treatment option for patients with EGFR-positive lung cancer.
June 14, 2016
Video
Heather A. Wakelee, MD, discusses a study utilizing liquid biopsies in patients with non-small cell lung cancer who harbor EGFR mutations.